Interleukin (IL)-22, which is derived from innate lymphoid cells (ILC)-3 and Th17 cells, plays an important role in intestinal host defense since mice deficient in IL-22 or its receptor, IL-22Ra1, are highly susceptible to multiple models of intestinal inflammation. In the past 10 years substantial progress has been made in our understanding of the IL-22-mediated mucosal host defense responses in the intestine; however, serious gaps in our knowledge remain. The pleiotropic effects of IL-22, coupled with the diverse array of intestinal cell types that express IL- 22Ra1, limit our ability to target this pathway therapeutically. It remains unclear how IL-22 interacts with functionally distinct epithelial cell lineages (absorptive or secretory) and intestinal stem cells (ISCs). The goal of this proposal is to understand whether IL-22Ra1 signaling in Paneth and/or intestinal stem cell (ISCs) regulates IL-22-mediated protection. We will assess the mechanistic nature of that protection on distinct epithelial compartments using cell-specific knockout mice and recombinant IL-22.Fc protein approaches. Towards this end, we generated 1) entire gut epithelium, 2) Lgr5+ ISCs, and 3) Paneth cell-specific conditional IL-22Ra1 knockout mice. We have accumulated critical data that lack of intestinal IL-22Ra1 signaling leads to a defect in Paneth cell-specific functions as well as enhanced susceptibility to Salmonella Typhimurium. Thus, based on the strength of our preliminary results, we hypothesize that IL-22Ra1 signaling in Paneth cells modulates intestinal host defense by regulating post-translational modifications of a-defensins and maintaining ISCs niche.
In specific Aim 1, we will determine whether IL-22Ra1 signaling in Paneth cells regulates post-translational modification of a-defensins and maintains ISCs niche.
In Aim 2, we will investigate whether Paneth, ISCs and/or absorptive enterocytes-specific role of IL-22Ra1 signaling is required to control S. Typhimurium-induced inflammation. These studies will provide critical new mechanistic information about specific cellular niches of IL- 22Ra1-signaling in the gut and their involvement in disease development, maintenance and therapeutic outcomes.

Public Health Relevance

Interleukin (IL)-22, plays an important role in intestinal host defense. However, little is known regarding the specific cellular niches of IL-22-mediated protective responses in intestines. Using Paneth and intestinal stem cells lineage-specific IL-22 receptor (IL-22Ra1) knockout mice our study will unravel the impact of IL-22 signaling on specific cell types and their involvement in mucosal host defense.

National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Exploratory/Developmental Grants (R21)
Project #
Application #
Study Section
Gastrointestinal Mucosal Pathobiology Study Section (GMPB)
Program Officer
Rothermel, Annette L
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
State University New York Stony Brook
Schools of Medicine
Stony Brook
United States
Zip Code